The report offers detailed coverage of Phenylketonuria (PKU) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Phenylketonuria (PKU) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Phenylketonuria (PKU) refers to a genetic disorder and the disease is inherited from one\'s parents. The patient suffers from a metabolic defect, in which the body stops being able to break down phenylalanine amino acid that is compromised of protein. Phenylalanine starts getting stored in the blood stream and it damages the brain in consequence.
PKU is caused due a defect in the gene which helps to produce phenylalanine hydroxylase. Absence of phenylalanine hydroxylase leads to a buildup of phenylalanine in the body. Timely diagnosis and treatment helps in terminating the symptoms of PKU and avoid brain damage.
The classification of Phenylketonuria (PKU) includes medications, supplements and others, and the revenue proportion of supplements in 2016 is about 34.48% and the revenue proportion of medications is about 42.47%.
Phenylketonuria (PKU) is widely used in household, hospital and other field. The most proportion of Phenylketonuria (PKU) is in household, and the sales proportion in 2016 is about 61.54%.
North America is the largest consumption place, with a consumption market share nearly 57.18% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 29.28%.
The report forecast global Phenylketonuria (PKU) market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2027.
First, this report covers the present status and the future prospects of the global Phenylketonuria (PKU) market for 2015-2027.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Biomarin
Vitaflo
Mead Johnson
Nutricia
Abbott
Prominmetabolics
Cambrooke
Juvela
Firstplay Dietary
At the same time, we classify Phenylketonuria (PKU) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Medications
Supplements
Market by Application
Household
Hospital
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Phenylketonuria (PKU) market for the forecast period 2021 - 2027?
• What are the driving forces in the Phenylketonuria (PKU) market for the forecast period 2021 - 2027?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Phenylketonuria (PKU) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?